This inventor holds 1 USPTO granted patent. Top assignee: Haemopep Pharma Gmbh. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Markus Magerlein: Patent Inventor in Obernburg
Introduction
Markus Magerlein is an inventor associated with Obernburg, Germany. His patent work includes an invention concerning antibodies that bind peptides from the human parathyroid hormone (hPTH) sequence (1–37). The available information lists 1 patent for him.
Latest Patents
Magerlein is named on the patent “Antibodies that bind peptides from the hPTH sequence (1–37).” The invention focuses on antibodies that bind peptides derived from a specific segment of the hPTH sequence.
Career Highlights
Magerlein is associated with Haemopep Pharma GmbH. His listed patent reflects work in antibody-related research and biotechnology.
Collaborations
His listed coworkers include Knut Adermann and Dieter Hock.
Conclusion
Markus Magerlein’s recorded patent activity centers on antibodies targeting peptides from the hPTH sequence, alongside his association with Haemopep Pharma GmbH.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile